quetiapine

(redirected from Seroquel XR)
Also found in: Medical.

quet·i·a·pine

 (kwə-tī′ə-pēn′)
n.
An antipsychotic drug, C21H25N3O2S, that acts as an antagonist of multiple neurotransmitters including serotonin and norepinephrine and is used in its fumarate form to treat schizophrenia and bipolar disorder.

[que-, origin unknown + t(h)ia(ze)pine, one of its chemical constituents (thi(o)- + az(o)- + ep(oxide) + -ine).]
Translations

quetiapine

n quetiapina
Mentioned in ?
References in periodicals archive ?
Mainly due to a 43% decline in Crestor sales and the 62% decline in Seroquel XR sales.
M2 EQUITYBITES-May 17, 2017-Pharmadax wins US FDA approval for generic Seroquel XR to treat schizophrenia
M2 PHARMA-May 17, 2017-Pharmadax wins US FDA approval for generic Seroquel XR to treat schizophrenia
This will be followed by a more gradual contraction in market size between 2017 and 2020 due to the generic erosion of other key brands such as Dainippon Sumitomo's Latuda and AstraZeneca's Seroquel XR.
The drugs Claxton and Perdue were promoting, Seroquel and Seroquel XR, are used to treat schizophrenia, major depressive disorder and bipolar disorder.
Pharmaceutical giant AstraZeneca made slight gains after a US district court ruled its patent for depression treatment Seroquel XR was valid.
The court dismissed AstraZeneca's bid to expand patents on the medication's active ingredient, quetiapine, and on the formula for Seroquel XR, the extended-release version.
said a 12-month study enrolling 292 adult patients showed its schizophrenia treatment Latuda was not inferior to AstraZeneca PLC's Seroquel XR.
NORDIC BUSINESS REPORT-October 5, 2011--AstraZeneca, Accord, Intas settle Seroquel XR patent dispute(C)2011 M2 COMMUNICATIONS http://www.
By delaying competition until then, AstraZeneca gains valuable breathing-space to allow its new version of the medicine, Seroquel XR, to capture market share.
M2 EQUITYBITES-October 10, 2016-Intellipharmaceutics wins US FDA tentative approval for generic Seroquel XR for schizophrenia and bipolar disorder
M2 PHARMA-October 10, 2016-Intellipharmaceutics wins US FDA tentative approval for generic Seroquel XR for schizophrenia and bipolar disorder